BE658905A - - Google Patents

Info

Publication number
BE658905A
BE658905A BE658905DA BE658905A BE 658905 A BE658905 A BE 658905A BE 658905D A BE658905D A BE 658905DA BE 658905 A BE658905 A BE 658905A
Authority
BE
Belgium
Application number
Inventor
E H Gans
H M Apelian
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of BE658905A publication Critical patent/BE658905A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE658905D 1964-01-27 1965-01-27 BE658905A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US340496A US3388041A (en) 1964-01-27 1964-01-27 High dosage sustained release tablet

Publications (1)

Publication Number Publication Date
BE658905A true BE658905A (fr) 1965-07-27

Family

ID=23333604

Family Applications (1)

Application Number Title Priority Date Filing Date
BE658905D BE658905A (fr) 1964-01-27 1965-01-27

Country Status (9)

Country Link
US (1) US3388041A (fr)
BE (1) BE658905A (fr)
BR (1) BR6566484D0 (fr)
DE (1) DE1492107C3 (fr)
ES (1) ES308585A1 (fr)
FI (1) FI51046C (fr)
FR (1) FR4768M (fr)
GB (1) GB1070492A (fr)
SE (1) SE375236B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255002A1 (fr) * 1986-07-23 1988-02-03 ALFA WASSERMANN S.p.A. Formulations pharmaceutiques à libération programmée contenant des agents antiphlogistiques
EP0384514A2 (fr) * 1989-02-21 1990-08-29 Norwich Eaton Pharmaceuticals, Inc. Comprimé à double effet
WO1993002662A1 (fr) * 1991-07-26 1993-02-18 L.C. Pharchem Ltd. Compositions pharmaceutiques antivirales administrees par voie vaginale
WO1993005769A1 (fr) * 1991-09-17 1993-04-01 Martti Lauri Antero Marvola Preparations pharmaceutiques a liberation regulee
FR2723586A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Nouvelles compositions contenant de la cimetidine et associations en derivant

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449489A (en) * 1965-10-21 1969-06-10 William E Gaunt Pharmaceutical compositions and their preparation
US3523141A (en) * 1967-04-26 1970-08-04 Nippon Zeon Co Method for inhibiting polymerization of conjugated dienes
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
JPS5661311A (en) * 1979-10-25 1981-05-26 Fujisawa Pharmaceut Co Ltd Thial amide or prolonged pharmaceutical preparation comprising its salt
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
WO1981002671A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2007065559A1 (fr) * 2005-11-18 2007-06-14 Synthon B.V. Comprimés de zolpidem

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798443A (en) * 1954-07-21 1957-07-09 Smith Kline French Lab Multilayer tablet compressing machine
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
BE627516A (fr) * 1962-01-25
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255002A1 (fr) * 1986-07-23 1988-02-03 ALFA WASSERMANN S.p.A. Formulations pharmaceutiques à libération programmée contenant des agents antiphlogistiques
EP0384514A2 (fr) * 1989-02-21 1990-08-29 Norwich Eaton Pharmaceuticals, Inc. Comprimé à double effet
EP0384514A3 (fr) * 1989-02-21 1991-04-03 Norwich Eaton Pharmaceuticals, Inc. Comprimé à double effet
WO1993002662A1 (fr) * 1991-07-26 1993-02-18 L.C. Pharchem Ltd. Compositions pharmaceutiques antivirales administrees par voie vaginale
WO1993005769A1 (fr) * 1991-09-17 1993-04-01 Martti Lauri Antero Marvola Preparations pharmaceutiques a liberation regulee
FR2723586A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Nouvelles compositions contenant de la cimetidine et associations en derivant
WO1996004892A1 (fr) * 1994-08-11 1996-02-22 Pharma Pass Nouvelles compositions contenant de la cimetidine et associations en derivant

Also Published As

Publication number Publication date
DE1492107B2 (de) 1973-04-26
DE1492107A1 (de) 1969-07-17
ES308585A1 (es) 1965-08-16
FR4768M (fr) 1967-01-23
GB1070492A (en) 1967-06-01
SE375236B (fr) 1975-04-14
DE1492107C3 (de) 1973-12-06
US3388041A (en) 1968-06-11
FI51046C (fi) 1976-10-11
FI51046B (fr) 1976-06-30
BR6566484D0 (pt) 1973-07-17

Similar Documents

Publication Publication Date Title
FI51046B (fr)
AU442366B2 (fr)
BE642212A (fr)
BE642104A (fr)
BE432268A (fr)
BE47396A (fr)
BE483969A (fr)
BE507097A (fr)
BE661184A (fr)
BE661167A (fr)
BE661084A (fr)
BE660944A (fr)
BE518974A (fr)
BE660731A (fr)
BE642243A (fr)
BE660097A (fr)
BE659610A (fr)
BE659474A (fr)
BE658952A (fr)
BE564626A (fr)
BE658368A (fr)
BE658299A (fr)
BE658256A (fr)
BE658219A (fr)
BE584699A (fr)